April 9, 2024 | Client News
Company Currently Has No Outstanding Convertible Investments Remaining Bakersfield, CA, April 09, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, announced that on April 8, 2024, filed a Form 8-K with the Securities and Exchange Commission (“SEC”) detailing the terms and conditions under […]
April 9, 2024 | Client News, NASDAQ: OKYO
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]
April 9, 2024 | Client News
Full year 2023 revenue increases approximately 70% year-over-year to $16.7 million Outlook for growth in the pet health sector remains attractive with active pipeline of acquisition opportunities Implemented cost reduction initiatives to maximize operational efficiency to deliver profitable growth Major reduction of consultant fees and other discretionary expenses post IPO SG&A savings of at least […]
April 9, 2024 | Client News, NASDAQ: LGVN
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the pricing of a public offering of 2,234,043 shares of the Company’s Class […]
April 8, 2024 | Client News, NASDAQ: LGVN
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders. Dear Shareholders, I am delighted to mark my first anniversary as CEO of Longeveron this month. It has been an extraordinary journey thus […]
April 8, 2024 | Client News
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today announced the execution of a non-binding Letter of Intent to acquire a large, established millwork, cabinetry and door manufacturer based in […]
April 8, 2024 | Client News
Show with Joel Block, “Your Advantage Play®, In Search of the Ultimate Competitive Advantage” MELBOURNE, Australia, April 08, 2024–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s CEO, Mr. James Nathanielsz, shares his views […]
April 4, 2024 | Client News
LISHUI, China, April 4, 2024 /PRNewswire/ — CN Energy Group. Inc. (Nasdaq: CNEY) (the “Company” or “CN Energy Group”), a high-tech enterprise specializing in cogeneration of high-quality wood-activated carbon and clean energy, today announced that Steven Berman, Chief Executive Officer of CN Energy Group, will participate in The Aegis Capital Corp 2024 Virtual Conference scheduled for Tuesday, May 7th, 2024, […]
April 3, 2024 | Client News
CEO, Steven Berman, Dives into Transforming Waste into Profitable Renewable Energy New York, New York—(Newsfile Corp. – April 2, 2024) – CN Energy Group Inc. (NASDAQ: CNEY) (“the Company”), is excited to announce its CEO, Steven Berman, recently sat down for an interview with SmallCaps Daily. During the interview, Berman highlighted the Company’s innovative technologies in producing […]
